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ABSTRACT

Alston, Aliza T. HUMAN PAPILLOMAVIRUS KNOWLEDGE AND AWARENESS
AMONG NORTH CAROLINA COLLEGE STUDENTS. (Major Advisor: Dr. Doretha
B. Foushee), North Carolina Agricultural and Technical State University.

The objective of the present study is to ascertain overall knowledge, attitude and
awareness of students at select North Carolina Universities about HPV, the HPV vaccine
Gardasil and the connection between HPV and various cancers. Five hundred and two
university students (NCAT, NCCU, ECU and UNCG), 303 females and 199 males, ages
18 or older (89.6% were between the ages of 18-22) participated in a cross-sectional
study by completing a survey. Students at these universities were randomly selected
based on their enrollment in introductory biology courses for non majors. Other students
were chosen randomly by face to face contact in heavily populated areas on the
campuses, such as the cafeterias, computer labs, libraries, and Student Unions. The
survey participants were asked questions about their gender, ethnicity, age,
classification, hometown, major, sources from which they receive information on
sexually transmitted diseases, sexual activity, sexual partners and date of last physical
examination. Participants were then asked a series of knowledge and awareness
questions about the human papillomavirus. Questions followed to ascertain if participants
had been diagnosed with HPV, their awareness of the HPV vaccine Gardasil, and
whether or not participants had been vaccinated with the Gardasil vaccine. A knowledge
scale from 0-18 was designed to look at the overall knowledge of college students.

The

mean knowledge score was 8.79. About 65% of the students scored a nine or less. More
xiii

than half of the students answered 50% of the questions incorrectly showing poor
knowledge of HPV. Close to 75% of the population scored a 14 or less representing an
unsatisfactorily level of knowledge. The population was divided into thirds by either
wanting to be vaccinated, not being interested in receiving the vaccine, or having been
vaccinated with the Gardasil Vaccine. The majority of the students who had not been
vaccinated with Gardasil reported that it was due to a lack of information on the vaccine
and the disease. More emphasis should go towards the development of educational
materials that educate young adults on the benefits of the HPV vaccine Gardasil.

xiv

CHAPTER 1
Introduction

Human papillomavirus (HPV) is a member of the Papovaviridae family. More
than 100 types of HPV, a double stranded DNA tumor virus, exist and are directly related
to numerous health conditions such as cancer and genital warts. The viruses of the
Papovaviridae family are all small and nonenveloped, meaning that they have no lipid
bilayer surrounding their capsid, the protein coat surrounding the genome. “Their capsid
is an icosahedron, or a polygon with 20 faces and is 55-nm in diameter” (Baldwin,
Edwards, Grace, Hayakawa, Huh, Nguyen, Münger, & Owens, 2004; Greenblatt, 2005;
Sinal & Woods, 2005). The most common types of Human Papillomavirus are types 6,
11, 16, and 18. The development of genital warts is primarily induced by HPV types 6
and 11, while HPV types 16 and 18 are associated with the development of
approximately 70% of all cervical cancers (Bosch, Castellsague, Diaz, de Sanjose,
Hammouda, Shaw, Meijer, & Munoz, 2004; Lowy, Kirnbauer & Schiller, 1994). The
human papillomavirus is as regular as the common cold. Currently, it is estimated that 20
million Americans are infected with HPV and that another 6 million will become infected
each year (Centers of Disease Control and Prevention [CDC], 2010). The Center for
Disease Control and Prevention (CDC) has estimated that 50% of sexually active
individuals will acquire a general human papillomavirus infection during their lifetime.
Human papillomavirus statistics indicate that the chance of a sexually active individual
becoming infected with HPV during his or her lifetime is 75% or higher. Human
1

papillomavirus spreads by intimate skin to skin contact, and by sexual activity, including
oral sex. Although there are treatments for the clinical manifestations of HPV infection,
there is no cure for the infection (Akers, Andraos-Selim, Bondzi, Edwards, Gollim,
Hagan, Heron, Jones, E.A., Jones, J., Moss, Smith, Taioli, Thurman, & Ragin, 2009).
Almost twenty years ago, researchers discovered a link between HPV and cervical
cancer (CDC, 2010). Cervical cancer is the second most common cancer among women
world-wide and is the leading cause of female cancer deaths in developing countries
(Parkin, 2005). Women usually receive the Papanicolaou (Pap) Smear Test yearly in
developed countries. If the test is abnormal, additional cytological test are implemented
to determine if the individual has cervical cancer (Beusterien, Dixon., Fleurence, &
Milanova, 2007). “Potential cell findings can range from atypical squamous cells of
undetermined significance; atypical squamous cells cannot exclude high-grade squamous
intraepithelial lesion; atypical glandular cells; high-grade squamous intraepithelial lesion;
and low-grade squamous intraepithelial lesion” (Cox, Massad, Twiggs, Wilkinson, &
Wright, 2002). Research has indicated that 99% of all cervical cancers, are caused by
high risk HPV virus types 16 and 18 (CDC, 2010). In most cases the body is able to clear
the HPV infection; however, if the infection is not cleared, an accumulation of abnormal
cells could develop in the cervix. The abnormal cells caused by HPV are directly linked
to cervical cancer.
Currently, thirty types of the HPV are linked to anal or penile cancers in men.
Less than one percent of the males in the United States were estimated to have been
diagnosed with penile and anal cancer in 2007 (CDC, 2010). Men have less prevalence
2

and incidence of cancers induced by HPV than women. However, the risk of anal cancer
is seventeen times more likely for bisexual or homosexual men in comparison to men
who are heterosexual (CDC, 2010).
There is no cure for HPV, simply treatment for the irregularities caused by HPV.
Maintaining abstinence from sexual activity is the only certain way to prevent HPV. The
usage of condoms reduces the risks of contracting HPV; however, areas that are not
covered by the condom are open to exposure to HPV. Individuals can lower their risk of
HPV by limiting sexual partners, staying in monogamous relationships, and selecting a
partner with limited previous partners. Before individuals become sexually active, or
after becoming sexually active and before being exposed to the HPV, it is imperative that
individuals receive the HPV vaccine. This will decrease the spread of HPV, and the
number of cases of genital warts and cancers linked to HPV.
Recently, the United States (US) Food and Drug Administration (FDA) approved
Gardisil, the first vaccine which is effective against human papillomavirus types 6, 11,
16, and 18, for young men and women between the ages of 9 to 26. The vaccine,
manufactured by Merck Pharmaceutical Company, was originally approved for women in
June 2006 and for men on October 9, 2009 (CDC, 2010). Gardasil is currently being
offered for approximately $120 per single dose. Gardasil requires three doses during the
duration of 6 months, a total cost of $360. Additionally, some physicians charge office
visit and injection fees at the time of vaccination. Though another vaccine,
GlaxoSmithKline’s Cervarix, was approved by the FDA in 2009 to protect against strains
16 and 18, the focus of this research will be specifically on Gardasil. Gardasil is the most
3

popular vaccine in the United States, as it has been on the market the longest and its
familiarity to society is greater.
We hypothesize that college students will be aware of HPV overall, but that
there will be misconceptions about the virus and only a few students will have been
vaccinated. We further hypothesize that qualitative factors will correlate directly to the
amount of knowledge and awareness about HPV and the attitude of students towards the
Gardasil vaccine.
Students at four universities in North Carolina were administered a twenty-seven
question survey. Data was analyzed using SPSS Software.
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CHAPTER 2
Literature Review

2.1 Papillomavirus Discovered
The first papillomavirus, the cottontail rabbit papillomavirus (CRPV), was
discovered in the 1930s by Richard Edwin Shope. Cottontail Rabbits in northwestern
Iowa and southern Kansas were described by hunters as having, “numerous horn-like
protuberances on the skin of various parts of the body” (Shope, 1933). The
protuberances are now referred to as “warts.” Peyton Rous and Joseph Beard exposed
“the cancerous potential of the wart virus in 1935, by showing it failed to replicate and
produce warts in the domestic rabbit, but instead induced the formation of skin
carcinomas after an extended period of time” (Beard & Rous, 1935). The first known
tumor virus, CPRV became an important model for showing the progression of
carcinomas. Not until 30 years later, when HPV infection was connected to human
cancer, would the significance of work done by Richard Shope, Peyton Rous and Joseph
Beard be recognized for its upmost importance ( Butel & Javier, 2008).

2.2 Classification and Structure of HPV
The human papillomavirus is classified as a member of the Papovaviridae family.
This is a large family of double stranded DNA tumor viruses (Baldwin et al., 2004;
Doorn, Kleter, Molijin, & Quint, 2005; Greenblatt, 2005; Sinal & Woods, 2005). The
HPV genome contains 8 kb of double stranded circular DNA. Currently, over a hundred
5

different strains of this virus have been identified that directly infect human beings. The
viruses of the Papovaviridae family are all small and nonenveloped, meaning that they
have no lipid bilayer surrounding their capsid, the protein coat surrounding the genome.
The shape of the capsid is an icosahedron with 20 faces, and is 55-nm in diameter
(Baldwin et al., 2004; Greenblatt, 2005; Sinal & Woods, 2005). The genome has eight
open reading frames coding for early proteins (E1, E2, E4, E5, E6, and E7) and late
capsid proteins (L1 and L2). Early proteins E1 and E2 participate in viral replication.
The E4 protein contributes to controlling the host cell cycle, and E5 assists in cell
transformation and viral replication. Oncoproteins E6 and E7 take part in malignant
transformation of cervical cells; they also form specific complexes with tumor suppressor
gene products tumor protein 53 (p53) and retinoblastoma (pRb).
The human papillomavirus is categorized into high risk types (16, 18, 31, 33, 35,
39, 45, 51, 52, 56, 58, 59, 68, 73, and 82), probable high risk types (26, 53 and 66) and
low risk types (6, 11, 40, 42, 43, 44, 54, 61, 70, 72, 81, and CP6108) (Bosch et al.,
2004Gnanamony, 2007). High risk types of HPV 16 and 18 cause growth on the cervix
that are usually level and out of sight, when contrasted to the external warts caused by
low-risk types HPV 6 and 11 (Human Papillomaviruses and Cancer: Questions and
Answers, 2010). High risk types 16 and 18 cause cervical cancer, severe cervical
dysplasia, anogenital cancers, in addition to head and neck cancers (Rapose, 2009). It is
important to mention, that a great majority of high risk HPV infections go away on their
own and do not cause cancer (Castle, Rodriguez, Schiffman, & Wacholder, 2007).
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2.3 Life Cycle of HPV
The introduction of HPV into the human body is a controversial issue. Scientists
suggest the accessibility of HPV is permitted through a break in the stratified epithelium
cell layer (Doorbar, 2005). However, there is still a debate over the specific cell surface
receptor that allows the initial attachment of the virus. Scientists also suggest a
dependence on the presence of the linear polysaccharide, heparin sulphate (Cook,
Janesn, Joyce, Keller, Lehman, Przysiecki, Sands, & Tung, 1999). Heparin sulphate
attaches to different protein ligands to normalize numerous biological activities,
including tumor metastasis.
The human papillomavirus has been shown to penetrate through the host cell by
different pathways, namely clathrin-mediated endocytosis, caveolar endocytosis, and
clathrin- and caveolae-independent endocytosis. “In the course of the clathrin-mediated
endocytosis pathway, the binding of a ligand to a specific receptor clusters the ligandreceptor complexes in the coated pits on the plasma membrane. This pit invaginated and
pinched off from the plasma membrane forms intracellular clathrin-coated vesicles in
progress to early endosomes before being fused to form late endosomes or lysosome”
(Letian & Tianyu, 2010). The caveolar endocytosis pathway is used a lot less than the
clathrin- mediated endocytosis pathway. Research shows that HPV-31 uses caveolar
endocytosis by passing through the caveosomes, avoiding the endosomes, and moving to
the endoplasmic reticulum or the golgi apparatus (Campos, Ozbun, & Smith, 2007;
Holthusen, Laniosz, & Meneses, 2008). Clathrin- and caveolae-independent endocytosis
are the pathways used by HPV-16. Evidence is provided by “the transmembrane domain7

containing proteins tetraspanins that are able to interact laterally with each other and with
other transmembrane proteins to form tetraspanin-enriched microdomains (TEMs) ,
within which tetraspanins can control and modulate complicated activities including
adhesion, migration, and synapse formation, as well as endocytosis and exocytoses”
(Hemler, 2003; Levy & Shoham, 2005). The life cycle of human papillomavirus is still
not completely understood, considering the virus has over 100 different known strains
which take different pathways.

2.4 HPV and Cancer
Almost twenty years ago, researchers determined an association between HPV
and cervical cancer (CDC, 2010). Cervical cancer is the second most common cancer
among women world-wide and is the leading cause of female cancer deaths in developing
countries (Parkin, 2005). Sexually active women usually receive the Papanicolaou (Pap)
Smear Test as a part of their yearly physical examination in developed countries. If the
test is abnormal, different cytological test are implemented to determine if cancerous
cells are present on the cervix (Beusterien et al., 2007). “Potential cell findings can range
from atypical squamous cells of undetermined significance (atypical squamous cells
cannot exclude high-grade squamous intraepithelial lesion); atypical glandular cells;
high-grade squamous intraepithelial lesion; and low-grade squamous intraepithelial
lesion” (Cox et al., 2002). Research has indicated that 99% of all cervical cancers are
caused by high risk HPV types 16 and 18 (CDC, 2010). However, other high risk types
of HPV 18, 31, 33, 45 are also linked to cervical cancer. In most cases the body is able to
8

clear the infection of the system by HPV; however, if the infection is not cleared, an
accumulation of abnormal cells could still be present in the cervix. The abnormal cells
caused by HPV are directly linked to cervical cancers.
Currently, thirty types of the HPV are linked to anal and penile cancers in men.
The high risk cancers associated with anal cancers in men are HPV types 16, 18, 31, 33
and 45. Less than one percent of the males in the United States were estimated to have
been diagnosed with penile or anal cancers in 2007 (CDC, 2010). Men have less
prevalence and incidence of cancers induced by HPV than women. Research also
indicates that men who have been circumcised have a lesser chance of developing HPV.
However, the risk of anal cancer is seventeen times more likely for bisexual or
homosexual men in comparison to men who are heterosexual (CDC, 2010).
In 2007, a case-control study showed that individuals with high numbers of oral
sex partners were three times as likely to develop Oropharyngeal cancer caused by HPV
16 (Gypsyamber, 2007). Also, the study indicated a higher risk of throat cancer by
eightfold for individuals with more than six oral sex partners. A review of the literature
also showed that HPV 16 and 18 were also linked to head and neck cancers. Head and
neck cancers are extremely rare, affecting below one percent of Americans a year.
However, the incidence of head and neck cancers is increasing.

9

2.5 Gardasil and Cervarix
Currently on the market are two vaccines, Gardasil and Cervarix, that provide
immunity against HPV types 16 and 18. Gardasil is a quadrivalent vaccine, because it
also provides immunity for HPV types 6 and 11 which are linked to genital warts and
respiratory papillomatosis. Gardasil has been on the market the longest and provides
protection for young males and females between the ages of nine and twenty-six.
Cervarix is a bivalent vaccine that provides protection for women between the ages of ten
and twenty-five. Both vaccines are made using recombinant DNA technology. Cervarix
contains inactive purified L1 proteins of HPV types 16 and 18; Gardasil contains purified
L1 proteins of HPV types 6, 11, 16 and 18. A cell that has been engineered to contain the
L1 gene allows the vaccines to produce the L1 protein. The proteins assemble to form
virus like particles. Both vaccines have an adjuvant system containing an aluminum
compound. Adjuvants are used to help stimulate a better immune response to
vaccination.
Many clinical trials have been conduct on these two vaccines. A head to head
clinical trial study sponsored by the Cervarix manufacturer, GlaxoSmithKline, indicates
that Cervarix also generates cross protection against high risk HPV types 31, 33, and 45.
It was also reported that Cervarix induces larger serologic responses against HPV types
16 and 18 in comparison to Gardasil. Overall, the two vaccines efficiently protect
women against cervical cancer. Close to thirty million doses of Gardasil were
administered in the United States in 2010. Gardasil is the popular vaccine in the United
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States, as it has been on the market the longest and its familiarity to women and doctors is
greater. This is the primary reason that our research will focus solely on Gardasil.

2.6 Immune Response to the Gardasil Vaccine and HPV Infections
The Gardasil vaccine is injected into the upper arm or upper thigh of the body. A
total of three injections of the Gardasil vaccine must be administered within a six month
period. The virus-like proteins (VLPs) in Gardasil are very similar to the HPV virus.
“Virus-like particles (VLPs) are multiprotein structures that mimic the organization and
conformation of authentic native viruses but lack the viral genome, potentially yielding
safer and cheaper vaccines” (Alves, Carrondo, Castilho, & Roldão, 2010). The proteins
have the ability to activate the innate (birth) and adaptive (acquired) immune response
(Mariani, & Venuti, 2010). When Gardasil is injected into the body, the immune system
realizes the VLPs found in Gardasil are foreign. Then the immune system starts to
develop antibodies against the VLPs to provide immunity. If the body is exposed to HPV
after vaccination, the body will be prepared to fight off the infection. Currently, research
is being conducted to see how long the vaccine provides immunity and determine if a
booster shot should be administered to induce the development of a more robust immune
memory.
Genital HPV infection is primarily a sexually transmitted infection but penetrative
vaginal or anal sexual intercourse is not a prerequisite for infection. Virus is also
transmitted by skin to skin contact via intimate contacts of the genitalia or other mucosal
11

surfaces (Kjaer, Moscicki, Schiffman, & Villa, 2006). Almost immediately after
becoming sexually active one is at their peak period for acquiring an HPV infection and
their chances increase with the number of sexual partners (Binns, Coleman, Deacon,
Desai, Elanko, Evans, Gilham, Haywod, Peto, Taylor, & Yule, 2004; Koutsky, 1997).
According to M. Stanley, many infected individuals mount an effective immune
response, becoming DNA negative with subsequent sustained clinical remission from
disease. Effective immunity requires a cell mediated response to proteins E2 and E6,
which is essential for lesion regression, accompanied by sero-conversion and antibody to
the major capsid protein L1 (Coleman, Crawford, Kwappenberg, Stanley, van der Burg,
van den Hende, & Woo,2010; Stanley, 2010). The immune response to HPV infection is
still not completely understood in its entirety.

2.7 Safety of the Gardasil Vaccine
The US Vaccine Adverse Event Reporting System (VAERS) reported a total of
12,424 adverse events after immunization with Gardasil in the United States between
June 2006 and December 2008 (Chustecka, 2009). At this time, an estimated 23 million
doses of Gardasil has been dispersed throughout the United States (Chustecka, 2009).
Seven hundred and seventy-two reports (6.2% of the total) were described as serious,
including 32 reports of death (Chustecka, 2009). The most frequently reported adverse
reactions were local injection site reactions, nausea, dizziness, and fainting (Agorastos,
Brotherton, Chatzigeorgiou, & Garland, 2009). In 2008 a meeting was held by the
Advisory Committee on Immunization Practices (ACIP) , an independent panel of health
12

expert (CDC, 2008), this committee found no epidemiological evidence of a link between
Gardasil and any serious adverse effects (Agorastos et al., 2009). The review of the
literature shows the risks associated with the vaccine are general when compared to that
of any vaccine currently on the market.

2.8 Knowledge and Awareness of HPV Studies
A survey was distributed to college students from Florida State University (FSU)
and Florida Agricultural & Mechanical State University in 2007. The purpose of the
study was to assess the awareness, knowledge, and beliefs about human papillomavirus in
a racially diverse sample of young adults. A total of 124 students participated in the 20
question survey. The study participants were of black or African-American descent by
57%, 32% white, 5% biracial, 3% Asian and 3% Latino/Latina (Gerend & Magloire,
2008). The results provided evidence that 75% of the students had heard of the human
papillomavirus, though there were misconceptions about the virus, general knowledge of
HPV was high (Gerend & Magloire, 2008). In their study, women had more knowledge
and awareness of the HPV than men. Participants with a high number of sexual partners
and those who were sexually active had a higher perception of risks associated with the
virus. The study participants who were less educated about the virus were younger in
age. The minority population, African Americans and sexually active participants
reported immense interest in HPV education. This is one of the first published
documents discussing the knowledge and awareness of a racially diverse group of young
college students in the United States.
13

The University of Pittsburgh surveyed 202 adults in the general population of
Pittsburgh, Pennsylvania, and Hampton, Virginia. The survey was used to evaluate
knowledge about HPV and the HPV vaccine, and the perception of the vaccines
efficiency and safety (Akers, et al., 2009). The methods used to distribute the surveys
were face to face or by mail. In Hampton, Virginia the participants were recruited
through flyers posted at churches, community centers, outpatient clinics, health fairs,
school events, libraries, the local newspapers, and the University of Pittsburgh Medical
Center newsletters (Akers, et al., 2009). The Hampton population consisted of
participants from Hampton and surrounding communities, such as the local plasma
donation center, churches, the local police station, and also students and staff members
from the Hampton University campus (Akers, et al., 2009). The ethnicity of survey
participants evaluated were 55% white, 45% black and 1% other for the two populations.
It was determined that the overall population 93.6%; Pittsburgh: 95%; Hampton: 90%
had heard of the human papillomavirus (Akers, et al., 2009).
The literature is very limited regarding the overall knowledge and awareness of
the HPV vaccine in young adults in the United States. Many Americans do have some
knowledge and awareness of HPV through internet sources, doctor visits, television
commercials and billboards. Research shows that around the world in Signapore,
Malyasia, Australia, and the Netherlands HPV vaccination programs are currently
ongoing. Surveys were conducted in these areas to test the current knowledge and
awareness of the human papillomavirus, to develop measurements to further educate their
citizens.
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2.9 Young Men’s and Women’s Attitude towards HPV
Prior to the Gardasil vaccine being made available to males, a private university
in the Northeast assessed the attitude towards the human papillomavirus in 2009. Six
focus groups composed of a total 45 men aged 18-22, participated in discussions that
were audio taped and transcribed verbatim, and initial coding categories were developed
(Allen, Fantasia, Fontenot, Flaherty, & Santana, 2009). It was found that the men had a
lot of misconceptions about the human papillomavirus. The majority acknowledged that
infection could be serious for women, and referred to HPV as a woman’s disease (Allen,
et al., 2009). Unfortunately, science reveals that this is not the case, because HPV is an
equal opportunity offender. They asked their participants if they would receive the
vaccine if it became available to them. In turn apprehension was voiced about the cost,
accessibility, safety and side effects (Allen, et al., 2009). Many males were hesitant to
receive the vaccination for themselves, men considered the vaccination of women would
be very beneficial (Allen, et al., 2009).
A study was conducted to see why only ten percent of young women in the
United States had been vaccinated against the human papillomavirus. One hundred and
eighty five non-vaccinated women aged 19-26 participated in the 2007 study. Most
respondents agreed that cervical cancer is a devastating disease (93.5%) and that genital
warts are an embarrassing condition (90.0%) (Good, Vichnin, Weiss, & Zimet, 2010).
The common perceived barriers to vaccinations was that the women were married or felt
as if they were in a true monogamous relationship. About a third of the respondents
thought the vaccine was too new or that they did not have enough information about it
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(Good, et al., 2010). There was also the concern about whether insurance companies
would cover the vaccination.
The attitude of both men and women seem to stem from a limited access to
information about the human papillomavirus infections, vaccine safety, and insurance
coverage.

2.10 Urban and Rural Defined
After reviewing the literature, it was determined that many different definitions
are used to define urban and rural. The Census Bureau divides "urban" into two different
categories either “urban cluster” or “urbanized area. Urban clusters have a population of
at least 2,500 but is less than 50,000. Urbanized areas have an urban nucleus of 50,000
or more people (U.S. Census Bureau, 2000). The Office of Management and Budget
(OMB), a federal agency that helps to advise the president on federal spending, has a
definition of “urban” based on Census data. The federal government has created many
different methods for defining rural America, which are used to delegate how
government funds are allocated to the public (Judge & Wingrove, 2004). There is no
universally accepted definition of “rural” across Federal Agencies (Judge & Wingrove,
2004). The Census defined "rural" as areas comprising open country and settlements
with fewer than 2,500 residents ( U.S. Census Bureau, 2000).
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2.11 North Carolina Demographics
In 2000, the United States Census Bureau reported that North Carolina was one of
the most rapidly growing states from the previous decade. According to the North
Carolina State Demographer, a majority of the population lived in 16 of the state’s 100
counties (Mecklenburg, Wake, Guilford, Forsyth, Cumberland, Durham, Buncombe,
Gaston, New Hanover, Union, Onslow, Cabarrus, Johnston, Davidson, Pitt, and
Catawba). Despite the growing populations, over a million North Carolinians are left
uninsured. Sadly, the highest groups of uninsured citizens are young adults ages 9-26.
To decrease this devastating statistic, the North Carolina University System mandated
that all college students who registered for classes in the fall of 2010 have health
insurance. The effects of the mandate should enhance vaccination rates and increase
awareness of the human papillomavirus.

2.12 Knowledge Gaps to be Addressed
The survey of the general populations of Pittsburgh, Pennsylvania, USA and
Hampton, Virginia, USA failed to explore proper assessment of one’s attitude towards
the HPV vaccine. The study focused more on perceptions towards the efficacy and safety
of the Gardasil vaccine. The survey of the two historically black universities in Florida
should have tested the majority populations (whites) as well for statistical purposes. My
research is intended to fill gaps of prior research studies, by looking at a greater number
of diverse populations by surveying racially diverse students at select North Carolina
Universities. The populations selected to be surveyed are East Carolina University,
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North Carolina Agricultural & Technical State University, North Carolina Central
University, and the University North Carolina at Greensboro. North Carolina Central
University and North Carolina Agricultural & Technical State University are historically
black public universities. East Carolina University and the University North Carolina at
Greensboro are two public universities that are historically white. The attitude and
knowledge of HPV will be addressed in men and women. Also we will look at the
hometown communities of survey participants, to determine if urban or rural areas have
more individuals who have received the Gardasil vaccination. The information gathered
from this research study will provide insight that will be used in the development of
educational materials designed to increase the knowledge and awareness of HPV and
HPV vaccinations, among college students.

2.13 Significance of this Research
Surveying diverse populations could generate data that will help with research in
the fields of marketing, preventive medicine, and clinical trials. Comparisons made from
the quantitative and qualitative analysis will contribute toward improved knowledge of
the relative importance of educating people on HPV and HPV vaccinations. Hence, this
knowledge will help decrease the number of infections and diseases caused by this virus.

18

CHAPTER 3
Materials and Methods

3.1 Survey Development and Design
The survey study was designed to ascertain knowledge and awareness of students
at select North Carolina Universities about HPV, the HPV vaccine Gardasil, and the
connection between HPV and various cancers . This study also sought to determine if
qualitative factors such as gender and ethnicity will influence the knowledge, awareness,
and attitude of students about HPV and the Gardasil vaccine. The survey participants
were asked questions that described their gender, ethnicity, age, classification ,
hometown, major, sources from which they receive information on sexually transmitted
diseases, sexual activity, sexual partners and date of last physical examination. For the
purpose of my study, “urban” is defined as those populations with more than 50,000
inhabitants. “Rural” is defined as those populations with less than 50,000 people.
Participants were then asked a series of knowledge and awareness questions about the
human papillomavirus. Followed by questions to ascertain if participants had been
diagnosed with HPV, their awareness of the HPV vaccine Gardasil, and whether or not
participants had been vaccinated with the Gardasil vaccine. The survey was pretested on
a small group of students and faculty members at North Carolina Agricultural &
Techinical State University and modified as necessary. We determined that the survey
instrument was validated to achieve the objectives of this study.
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3.2 Study Participants
College students attending East Carolina University (ECU), North Carolina
Agricultural & Technical State University (NCAT), North Carolina Central University
(NCCU), and the University of North Carolina at Greensboro (UNCG) were asked to
participate in this study. These schools were selected because they are all public
universities in the State of North Carolina. Two of the institutions, NCA&TSU and
NCCU, are historically black universities and two of the universities, ECU and UNCG,
are historically white. This voluntary survey was distributed to students at these
universities randomly selected based on their enrollment in introductory biology courses
required for non majors. This is a course required for all students regardless of their
major. Other students were chosen randomly by face to face contact in heavily populated
areas on the campuses, such as the cafeterias, computer labs, libraries, and Student
Unions.

3.3 Research Compliance
The survey entitled, “Human Papillomavirus (HPV) Knowledge and Awareness
among North Carolina College Students” and an informed consent form was reviewed
by the Institutional Review Board (IRB) at North Carolina Agricultural & Technical State
University, and was determined to be exempt from further review according to 45 CFR
46.101(b) (Appendix). The seal of approval was granted on October 5, 2010 by NCAT.
The North Carolina Agricultural & Technical State University seal of approval was then
recognized and accepted at East Carolina University, North Carolina Central University,
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and the University of North Carolina at Greensboro in the Fall semester of 2010
(Appendix).

3.4 Survey Administration Protocols
Participants were asked to read the Informed Consent Letter. They were also
made aware of the potential risks and benefits of participation in this survey. Participants
who voluntarily provided Informed Consent were asked to respond to survey questions.
Students required approximately 10 minutes to complete the survey responses. To
protect the privacy of study participants, surveys were collected by having students put
them in an envelope.

3.5 Statistical Analysis
The statistical computer software SPSS (V 18.0) was used to analyze the collected
survey data. Initially, descriptive analysis of the quantitative variables was conducted.
The relationship between students’ knowledge of HPV and the independent variables
(age, ethnicity, gender, major, and school) was determined using the chi-square test. The
significance level for this study was set at 5% (alpha = .05)
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CHAPTER 4
Results and Discussions

4.1 Characteristics of the Study Population
A total of 502 surveys were collected from students attending East Carolina
University, North Carolina Agricultural & Technical State University, North Carolina
Central University, and University of North Carolina at Greensboro (Figure 1.1). The
largest number of survey participants attended the University of North Carolina at
Greensboro (30.5%). North Carolina Agricultural & Technical State University
represented 27.3% and East Carolina followed closely at 24.3%. The lowest number of
respondents attended North Carolina Central University (17.9%). Each university
contributed between 17.9% to 30.5% towards the total population. In this study 60.4% of
the participants were female and 39.6% were males. This gender distribution was also
reflected within each school.
Past research studies in Florida compared students from a historically white
university (Florida State University) and a historically black university (Florida
Agricultural & Mechanical State University) as reported by Gerend and Magloire in
2008. The current study consisted of two historically white universities (ECU and
UNCG) and two historically black universities (NCAT and NCCU) in the state of North
Carolina. The current study surveyed four times as many students compared to the
Florida study which only surveyed 124 students.
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Figure 1.1 Distribution of Participants at the Four Selected Universities.
The percentage of survey respondents that attended East Carolina
University was 24.30%, North Carolina Agricultural & Technical State
University 27.29%, North Carolina Central University 17.93% and
University of North Carolina at Greensboro 30.48%.

4.1.1 Ethnicity. The largest ethnic groups were black and white as reflected in
Table 1.1. Less than 1% of the respondents identified themselves as Other or Native
American. Asian American, Southeast Asian /Asian and Hispanic/Latino were 2.2% of
the population. Individuals who classified themselves as multi- racial represented 6.6%,
54.4 % were of African American/Black/African Descent, and 33.5% were
Caucasian/White. All other ethnic groups together made up only about 10% and were
not included in further analyses. Therefore, we focused on African
American/Black/African Descent and Caucasian/White in this study.
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Table 1.1 Ethnic Distribution of the Participants
Ethnicity

Percent %

Asian American/ Southeast Asian/ Asian

2.2

African American/ Black/African Descent

54.4

Caucasian/ White

33.5

Hispanic/ Latino

2.2

Multi-Racial

6.6

Native American

0.6

Other

0.6

Total

100

4.1.2 Age Group. The vast majority of respondents (89.6%) were between the
ages of 18-22 (Figure 2.1). Less than 7% of the respondents were between the ages of
23-26 and only 3.4 % were older than 26. We expected that the majority of our
population would be between the ages of 18-22, because we were sampling colleges with
majority undergraduate students.
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Figure 2.1 Age Group Distribution of Survey Participants.
Respondents according to age were less than 18, 18-22, 2326, or older than 26.

4.1.3 Classification. Nearly 60% of all survey participants were freshmen or
sophomores. Juniors represented nearly 20% of the population and seniors 16%.
Graduate students were least represented in this sample (3.8%). We had student
representation from all classifications (Figure 3.1).
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Figure 3.1 Distribution of Participants’ Classification
Majority of survey respondents were sophomores or
freshmen 60.6%, juniors represented 19.5%, seniors
16.1% and graduate students 3.8%.

4.1.4 Major. Students of different majors participated in this survey. The most
common majors among the public universities were Economics/Business 15.3%, Nursing
8.96%, Civics/Social sciences 8.37% and Education 8.17% of the population. Other
majors represented in this study were Math/ Physics, Biology/Chemistry, Agriculture,
Animal Science, Athletic Training and Pre-Law. Although these majors were
represented in this study, they were not as well represented as the above mentioned
majors. A larger representation of biology and chemistry majors would have allowed us
to determine if there is a significant difference in the knowledge and attitudes of students
in majors typically considered to be more closely aligned with biomedical sciences.
Overall, a very diverse sample of majors was obtained from the study population.

26

4.2 Sources of Receiving Information on Sexually Transmitted Diseases
The most common ways college students receive information on STDs and STIs
is through the Physician or from the Student Health Center (74.5%); followed by the
internet (71.5%) (Table 2.1). Over 60% of the participants received information on STDs
and STIs by watching television or by word of mouth from parents, guardians or friends.
Less than 50% of the participants received information by reading magazines, books and
newspapers.

Table 2.1 Participants were asked for their Sources of Receiving Information
Related to Sexual Health and STDS
Sources of Information
Percentage of those Receiving
Information
Physician or Student Health Center

74.5%

Television

63.1%

Internet

71.5%

Health Classes

68.9%

Magazines, Books and Newspapers

44.0%

Word of Mouth (Parents/Guardian, Friends,
Teacher)

61.6%
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4.3 Physical or Gynecological Examinations
Fifty-four percent of the survey respondents had received a physical or
gynecological exam six months ago and 22.7% had received an examination within the
last year. Only 15% reported that they had received a physical examination more than a
year ago, and less than 10% of the population had never received a physical or
gynecological exam.
Overall, close to 90% of blacks had been examined by their physician within the
last year compared to 66.5% of whites. Almost two times as many blacks reported that
they had been examined by their physician six months ago in comparison to whites.
There are dramatic differences between the regularity of physician visits of
whites and blacks (Table 3.1). This data differs from a research study conducted by the
CDC which interviewed households from 1997-2009. Their research study showed no
significant difference between blacks (46.5%) and whites (46.8%) who reported visiting
their physician one to three times in 2009. The difference in the current study could be
because blacks have a higher risk for contracting such diseases like HIV. The Center for
Disease Control and Prevention reported that 52% of African Americans were diagnosed
with HIV in 2008; whereas only 29% of whites were diagnosed with HIV.
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Table 3.1 Physical Examinations amongst Blacks and Whites
African American/Black

Caucasian/White

Never

5.5%

11.9%

More than a year ago

8.4%

21.4%

A year ago

19.4%

29.2%

Six months ago

66.7%

37.5%

Total

100%

100%

4.4 Sexually Activity and Sexual Partners
Overall, 79.1% of the survey participants reported being sexually active, and
20.9% reported that they were not sexually active. Females (77.6%) and males (81.4%)
reported being sexually active. Almost an equal proportion (37%) had 0-1 or 2-3 sexual
partners in the last three years (Figure 4.1). Whereas 10.6% of the population had 4-5
sexual partners, and 16.3% had more than 5 sexual partners. Further analysis shows a
difference in sexual partners according to ethnicity and between white and black males.
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Figure 4.1 Distribution of Sexual Partners in the Last Three Years
Respondents reported the number of sexual partners they had within
the last three years. Students who reported zero to one were 36.5%,
two to three 36.7%, four to five 10.6% and more than 5 sexual
partners were 16.3%.

4.4.1 Sexual Activity by Gender and Ethnicity. Of those sampled, 84.6% of the
blacks reported being sexually active; while 70.8% whites were more likely to be in a
monogamous relationship when compared to blacks. As seen from Table 4.1 the highest
percentage of blacks (41.0%) reported they had two to three sexual partners in the last
three years. Blacks reported having four or more sexual partners at a higher rate than
Causasians/Whites.
Joy Kinnon, a reporter for Ebony Magazine, said “the bad news is that the number
of black married couples is only half the number of married whites, and the situations is
getting worse.” Kinnion also explained that blacks marry at a lower rate and at an older
age. The Joint Center for Political and Economic Studies reports that by the age 30, 81%
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of white women will be married, and only 52% of black women were married. Research
has proven that whites marry at a younger age than blacks. This may be a reason why
almost 50% of whites were more likely to be in a monogamous sexual relationship for the
last three years.

Table 4.1 Sexual Partners among Blacks and Whites
Number of Partners
Blacks

Whites

0-1

28.2%

47.6%

2-3

41.0%

30.4%

4-5

11.4%

8.9%

More than 5

19.4%

13.1%

Total

100%

100%

4.4.2 Sexual Partners by Gender and Ethnicity. The highest percentages of
individuals reporting having more than five sexual partners in the last three years were
black males (37.5%). On the other hand, the majority of the white males (43.5%) were in
monogamous relationships with 0-1 sexual partners in the last three years (Table 5.1).
Thirty percent of black and white males reported having only two to three sexual
partners. There was not a significant difference in sexual partners between white and
black females. Both reported having zero to three sexual partners in the last three years at
nearly 80%.
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Table 5.1 Sexual Partners in the last three years
Number of
Black Males
White Males

Black

White

Partners

Females

Females

0-1

20.5%

43.5%

33.5%

50.0%

2-3

30.4%

30.6%

48.4%

30.2%

4-5

11.6%

8.1%

11.2%

9.4%

More than 5

37.5%

17.7%

6.8%

10.4%

4.5 Knowledge of Human Papillomavirus
A total of 10 questions were used to determine the knowledge of college students.
Responses from Table 6.1 indicate that only 36.7% of the college students correctly
recognized that human papillomavirus is not a bacterial disease. More than half of the
students knew that human papillomavirus was the most common sexually transmitted
infection in the United States (58%). Survey participants also recognized the chance of
contracting human papillomavirus correctly at 52.2%. Of those students, 36.1%
answered that he/she has a 50% chance of contracting human papillomavirus in his or her
lifetime, which was the recognized percent from the Center for Disease Control. The
other 16.1% answered that there is a 75% chance of contracting human papillomavirus in
one’s lifetime which correlated with the data from Merck & Company. Respondents
correctly answered that between 30-40 types of human papillomavirus infect the genital
tract (63.7%).
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Only 28.5% of survey participants correctly answered that males and females are
infected equally with the HPV. A majority of the respondents 64.5% believed that
human papillomavirus infected females more than males. Only 7.0% answered that
males are usually infected with HPV more than females. When asked, “Does a condom
prevent transmission of human papillomavirus between partners,” 63.7% believed a
condom would prevent the transmission of HPV. Few answered correctly that a condom
would not prevent transmission of HPV between partners. Lastly, the vast majority of the
respondents, 68.3%, recognized that it would be acceptable for a person under age 26 to
receive the human papillomavirus vaccine before becoming sexually active or after
becoming sexually active, and after being exposed to the human papillomavirus. There
was no significant difference in the amount of knowledge in the white and black
populations.
Nearly 60% of males and females believe that a condom will prevent the
transmission of HPV; however, areas that are not covered by the condom are able to
contract the virus during sexual intercourse. Young adults also seem to be naïve to the
fact that HPV is an “equal opportunity offender” it does not infect females more than
males or vice versa according to the CDC. Less than 40% of the population correctly
responded that HPV is not a bacterial disease.
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Table 6.1 Knowledge and Transmission on Human Papillomavirus
Knowledge Test Questions
Correct Response %
Correct Response %
M
F
HPV is a bacterial disease?
36.7
32.2%
39.6%
(T/F)
HPV is the most common
58
41.7%
42.2%
Sexually Transmitted
Infection (STI) in the United
States? (T/F)
What is the chance that one
52.2
46.7%
55.8%
will contract HPV in his or
her lifetime?
How many types of HPV
63.7
60.3%
66.0%
infect the genital tract?
Which sex does HPV
28.5
34.1%
24.8%
usually infect?
Does a condom prevent
36.3
30.2%
40.3%
transmission of HPV
between partners? (T/F)
When could a person under
68.3
66.8%
69.3%
26 receive the HPV vaccine?

4.6 Knowledge of HPV Symptoms
College students were asked to check all of the symptoms associated with human
papillomavirus infections. The symptoms were genital warts in males, genital warts in
females, cervical cancer in females and throat and penis cancers in males. More than
50% of the students associated HPV with genital warts in females and cervical cancer in
females (Table 7.1). Fewer recognized that HPV was related to genital warts in males
(44%). Only a small number of respondents were aware that HPV was found in throat
and penis cancers in males (18.3%); and anal and oral cancers in both sexes (23.9%).
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Table 7.1 Knowledge on HPV Associations
HPV is associated with….
Correct Response %
Genital warts in males

44

Correct Response%
M
F
53.8
37.6

Genital warts in females
Cervical cancer in females

52.6
76.7

55.8
62.3

50.5
86.1

Throat and penis cancers in
males

18.3

23.6

14.4

Anal and oral cancers in
males and females

23.9

26.1

22.4

The study in Florida by Gerend and Magloire showed that survey participants
knew that some types of HPV can lead to cervical cancer (92%) and genital warts (69%).
The current study is showing that only 76.7% of college students knew that HPV was
associated with cervical cancer. More participants knew about symptoms in females than
those in males. The Greensboro Public Health Department also found that many people
believe that HPV is a “female disease.” There has to be a reason why there is a higher
rate of knowledge on HPV being associated with cervical cancer and genital warts in
Florida college students in comparison to that of North Carolina college students. Further
research needs to be done to evaluate educational measures pertaining to the human
papillomavirus in Florida in comparison to that of North Carolina.

4.6.1 Black and White Males (Knowledge of HPV Associations). White males
were more aware that HPV is associated with genital warts in males and females, than
were black makes and black and white females (Table 8.1). White and black females
were equally aware of HPV being associated with cervical cancer in females in
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comparison to black and white males. Black males were nearly 10% more aware of
throat and penis cancer in males than any other group, and white females and black males
had the highest knowledge of anal and oral cancers being related to HPV. Overall, there
seems to be a gender difference in students’ knowledge of the link between HPV and
genital warts and different cancers in males and females.

Table 8.1 Knowledge of HPV Associations between Black and White Males
Males Correct
Females Correct Response
HPV is associated with….
Response
Black

White

Black

White

48.2%

62.9%

35.4%

41.5%

50%

66.1%

51.6%

50.9%

Cervical cancer in females

66.1%

59.7%

87.6%

84.9%

Throat and penis cancers in
males

26.8%

16.1%

13.0%

15.1%

Anal and oral cancers in males
and females

26.8%

16.1%

16.8%

27.4%

Genital warts in males
Genital warts in females

4.7 Knowledge of HPV Infections
A large number of respondents were not aware that most types of HPV infections
are able to clear on their own and responded that they are unable to clear on their own
and require medical attention (74.3%). Only 18.9% of the respondents believed HPV
infections sometimes clear on their own (Table 9.1). Only 6.8% correctly answered, that
most types of HPV usually clear on their own. The responses from males and females
showed no gender difference in the knowledge of HPV associations. There was also no
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significant difference between white and black males knowledge on HPV associations.
The previous research study by Gerend and Magloire showed that less than 30% of
respondents knew that most types of HPVs clear on their own. Participants in this study
were asked if the statement was true or false, while participants in the present study were
asked in a multiple choice format. We believe the multiple choice format is more
reliable, because one does not have a 50% chance of guessing the correct answer.
Most students in this study had a higher perceived misconception of HPV
infections, because nearly 90% of HPVs clear on their own. Only 10% of the population
with HPV will develop symptoms and the strain of HPV is irrelevant. The students
probably associated HPV and related diseases with other sexually transmitted diseases
and infections most of which require medical attention. Diseases such as Gonorrhea,
Chlamydia, Syphillis and infection with human immunodeficiency virus always require
medical attention.

Table 9.1 Knowledge of HPV Infections
Most types of HPV infections…. Response %
Usually clear on their own
(Correct Response)

6.8

Females
Response %
6.6

Sometimes clear on their own

18.9

19.8

17.6

Are unable to clear on their own
and require medical attention

74.3

73.6

75.4

n=502

n=303

n=199

Total Response

37

Males Response %
7.0

4.8 Knowledge of HPV Transmission
Based on survey responses, 95.8% of the participants correctly answered, that
HPV cannot be transmitted by holding hands (Table 10.1). There were few respondents
that recognized that HPV could be transmitted by French kissing (15.9%) and intimate
skin to skin contact (32.9%). Most respondents correctly identified that HPV can be
transmitted by oral sex and sexual intercourse. A comparison of male and females
response rate to HPV transmission was similar. Further analysis determined that
knowledge of HPV transmission was not different between black and white populations.

Table 10.1 Distribution of Knowledge of HPV Transmission
HPV can be transmitted
Correct Response %
through…
Holding hands
French kissing
Intimate skin to skin contact
Oral Sex
Sexual Intercourse

95.8
15.9
32.9
72.9
95.8

Correct Response %
Males
Females
94.5
20.1
27.6
75.9
91.5

96.7
13.2
36.7
71.0
98.7

4.9 Knowledge Scale
A knowledge scale was created 0-18 to look at the overall knowledge of college
students (Figure 5.1). Participants received one point for every correct response and zero
points for every incorrect response. The average knowledge score was 8.79. Nearly 65%
of the students scored a nine or less showing poor knowledge of HPV. Close to 75% of
the population scored a 14 or less representing a lack of adequate knowledge. Only 1.2%
of the population scored between 15 and 16. No one received a perfect score out of 502
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survey participants. Overall, the HPV knowledge score of survey participants was very
poor. This differs from a similar study by Gerende and Magloire, which had evidence
that 75% of the students had heard of the human papillomavirus, though there were
misconceptions about the virus, general knowledge of HPV was high in Florida. The
current study showed no gender difference in the knowledge scale; even though females
had a slightly higher mean and median (Table 11.1). Further analysis was completed to
determine if knowledge scale depended on factors such as university, classification, or
ethnicity.

Figure 5.1 Distribution of Knowledge Scores
Students knowledge distribution on the human
papillomavirus (n=502) was overall low and graph is
skewed to the right.
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Table 11.1 Knowledge Scale by Gender
Gender
Mean/ Std.
Deviation

N

Median

F

8.87/(s=2.47)

303

9.00

M

8.67/(s=2.36)

199

8.00

Total

8.79/(s=2.43)

502

9.00

4.9.1 Knowledge Scores by University. A comparison of means examined the
knowledge scores of the universities sampled (Table 12.1). The highest scoring
universities were UNCG (8.95) and NCAT (8.93). The other two universities followed
closely behind ECU (8.76) and NCCU (8.37). Anova test showed there was no
significant difference between the knowledge scores between universities (p = .280). All
of the knowledge score means and medians for universities were between eight and nine
out of a possible 18 points. The averages seen at each university were similar to that of
the overall study population.

Table 12.1 Distribution of Knowledge Scores by University
College
Mean/Std.
Deviation
East Carolina University
8.76/(s=2.44)

N

Median

122

8.00

North Carolina Agricultural &
Technical State University

8.93/(s=2.38)

137

9.00

North Carolina Central University

8.37/(s=2.59)

90

8.00

University of North Carolina
Greensboro
Total

8.95/(s=2.35)

153

9.00

8.79/(s=2.43)

502

9.00
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4.9.2 Knowledge Scores by Classification. Graduate Students had a slightly
higher knowledge scores than freshmen, sophomores, juniors and seniors (Table 13.1).
However the graduate students (n=19) were a very small portion of our respondents and
were not considered a representative sample. Juniors had the lowest average knowledge
score. Sophomores had slightly more knowledge than freshman. In spite of this, there is
no significant difference between classification and knowledge scores. The Anova test
had an extremely high (p value = .379).

Table 13.1 Knowledge Scores by Classification
Classification
Mean/Std.
Deviation

N

Median

Freshmen

8.82/(s=2.60)

152

8.00

Sophomore

8.89/(s=2.87)

152

9.00

Junior

8.45/(s=2.38)

98

8.00

Senior

8.80/(s=2.53)

81

8.00

Graduate Student

9.58/(s=2.87)

19

9.00

Total

8.79/(s=2.43)

502

9.00
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4.9.3 Knowledge Scores by Ethnicity. A comparison of knowledge scores by
ethnicity showed that Asian American/Southeast Asian/Asian and Hispanics had the
highest scores (Table 14.1). However, they represented a very small portion of our
sample (n=22, .08). There was no significant difference of knowledge scores in African
American/Black/African Descent ethnicities to that of Caucasian/ Whites. Multi-racial
survey participants had a average knowledge score over nine. Native Americans scored
the lowest on the knowledge scale. They also had low representation in this study (n=3).
Gerend and Magloire 2008 also found no difference between knowledge scores
across ethnicity. However, it does differ from a study completed in Pittsburg by Akers et
al in 2009. Their study indicated that blacks were less aware of HPV than whites (Black
89% vs. Whites 97%, p > 0.1). Their survey was used to evaluate knowledge about HPV
and the HPV vaccine, and the perception of the vaccine‘s efficiency and safety (Akers, et
al., 2009).

Table 14.1 Comparison of Means by Ethnicity * Knowledge Score
Ethnicity
Asian American/ Southeast Asian/
Asian
African American/ Black/African
Descent
Caucasian/ White
Hispanic/ Latino
Multi-Racial
Native American
Other
Total

Mean/ (Std.
Deviation)
9.8/ (s=2.79)

N

Median

11

9.00

8.66/(s=2.47)

273

8.00

8.90/(s=2.42)
9.27/(s=2.76)
9.06/(s=1.90)
7.33/(s=1.15)
8.00/(s=2.65)
8.79/(s=2.43)

168
11
33
3
3
502

9.00
8.00
9.00
8.00
9.00
9.00
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4.10 Perception
Over 80% of our sample viewed their knowledge as average or poor (Figure 6.1).
Their actual knowledge scores supported their perception. It is interesting to note that the
way students perceived their knowledge was correct, because 75% of the population
scored poorly (knowledge score below 14) on HPV knowledge. Less than five percent of
the population perceived themselves to be well informed. Nearly a third of the
population perceived their knowledge as average.

Figure 6.1 Distribution of How Students Perceived their Knowledge of HPV
Based on survey responses 58% perceived their knowledge on HPV
as poor, 37.8% average, and 4.2% as well informed.
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4.10.1 Perception by Gender. A higher percentage of males perceived their
knowledge of HPV as poor than females (Table 15.1). More females thought their
knowledge of HPV was average. The actual mean knowledge score was higher in
females than males. The median for females was nine, and the median score for males
was eight. Overall, the perceived knowledge of males and females was similar to that of
actual knowledge (poor).

Table 15.1 Distribution of Perceived Knowledge by Gender to Actual Knowledge
Poor

Average

Well Informed

Actual Score
Mean/ Median

Females

53.1%

41.9%

5.0%

8.87/9.00

Males

65.3%

31.7%

3.0%

8.67/8.00

4.10.2 Perception in Blacks and Whites. Students’ perception of knowledge of
HPV was different between blacks and whites. Blacks had a higher perceived knowledge
of HPV to that of their white counterparts. Few survey participants reported that they
were well informed on the human papillomavirus. The actual mean knowledge score
showed that both populations actually had poor knowledge of HPV. Whites were slightly
more knowledgeable about HPV than blacks. However, there is no significant difference
between the knowledge score of the two populations.
Gender comparison by ethnicity in Table 16.1 showed that white females had the
highest actual knowledge score. However, all scores were very close together showing a
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tenth of a point difference. Median scores were highest in the all white sample and the
sample of white females. More white females perceived their knowledge as poor when
compared to black females. In general by gender and by ethnicity the overall knowledge
scores were still relatively low.

Table 16.1 Perception of Actual Knowledge by Gender and Ethnicity
Population
Poor
Average
Well
True
Informed

Knowledge
Score
(Mean/Max
score)

All Black

52.0%

42.1%

5.9%

8.66/18

Females

47.8%

44.7%

7.5%

8.69/18

Males

58.0%

38.4%

3.6%

8.63/18

All White

64.9%

32.7%

2.4%

8.89/18

Females

60.4%

37.7%

1.9%

9.00/18

Males

72.6%

24.2%

3.2%

8.71/18
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4.11 Attitude towards the HPV Vaccine Gardasil
Over 60% of the population wanted more information on the HPV vaccine
Gardasil (Figure 7.1). Nearly fifteen percent of the population did not know about the
vaccine and were not interested in receiving more information on Gardasil. Whereas,
fourteen percent of respondents believed that they knew everything about Gardasil.
There were gender differences between males and females (Figure 8.1). More than 50%
of the males did not know about Gardasil but would like more information. Nearly half
of the females reported they had heard of Gardasil but would like more information. The
findings of the current study were similar to that of Gerend & Magloire who found that
64% of their study population was interested in HPV education. A cross tabulation was
performed to see if there was a difference between white and black populations; and
white and black males. There was no significant difference to report. Since more than
half of the population was interested in learning more about the HPV vaccine, methods of
educating students about HPV and the vaccine should be implemented.
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Figure 7.1 Distribution of Students’ Attitude towards Gardasil
The percentage of survey respondents who did not know about the
vaccine and were not interested in receiving more information on
the vaccine were 14.9%, 31.3% did not know about the vaccine but
would like more information, 39.6% had some information on the
vaccine but would like more information, and 14.1% knew
everything about the HPV vaccine Gardasil.
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Figure 8.1 Attitude towards Gardasil Vaccinations by Gender
The distribution of attitudes on Gardasil Vaccinations by Gender
showed that 51.26% of males did not know about the vaccine but
would like more information and 51.82% of females had some
information on the vaccine but would like more information.

4.12 The HPV Vaccine Gardasil
The response to vaccinations was evenly divided with 31.87% of respondents
having been vaccinated, 34.26% having not been vaccinated but would like to be, and
33.86 % having not been vaccinated and do not want to be vaccinated (Figure 9.1).
Further analysis was done to see if gender, university and ethnicity played a role in
Gardasil vaccination rates.
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Figure 9.1 Distribution of Gardasil Vaccination
The percentage of students who did not want to be
vaccinated 33.86%, those who would like to be vaccinated
34.26%, and those that had been vaccinated 31.87%.

4.12.1 Gardasil Vaccination by Gender. A cross tabulation was performed to
determine the rate of Gardasil vaccination according to gender (Table 17.1). More than
half of the female participants had been vaccinated; whereas only 1% of male participants
had been vaccinated. The majority of the males had not been vaccinated and was not
interested in receiving the Gardasil vaccine. There is a statistically significant difference
in the Gardasil vaccination rates based on gender (x2 = 149.633, p=.001). Nearly 80% of
females had been vaccinated or would be interested in receiving the Gardasil vaccine
Figure 10.1. Less than a quarter of females were not interested in receiving the Gardasil
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vaccine. On the other hand, more males (54.3%) were not interested in being vaccinated
with Gardasil, but a large portion (44.7%) would consider being vaccinated.

Figure 10.1 Gardasil Vaccinations by Gender
The graph shows the percentage of students who did
not want to be vaccinated, those that would like to be
vaccinated, and those that have been vaccinated
according to gender.

Gardasil was originally approved (June 2006) for females and recently approved
three years later for males (November 2009) by the Food and Drug Administration.
More efforts have been made to target females, since the vaccine has been available for
females longer. Even though Gardasil was approved for males, few campaigns or
advertisements have been promoting the vaccination of males. Numerous Gardasil
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advertisements show the faces of women and young females in their campaigns. This
could be the reason that 50% of males are hesitant to receive the Gardasil vaccine.

Table 17.1 Gardasil Vaccination based on Gender

Gender
Gardasil No, and I do not want
to be vaccinated
No, but I would like to
be vaccinated
Yes, I have been
vaccinated
Total

F
62

M
108

20.4%
83
27.4%
158
52.1%
303

54.3%
89
44.7%
2
1.0%
199

100%

100%

4.12.2 Gardasil Vaccination by University. There was a statistically significant
difference between Gardasil Vaccinations between universities (x2 =28.39, p value =
.001; Figure 11.1). The University of North Carolina at Greensboro had the highest
percentage of students who had been vaccinated and the highest number of students who
did not want to be vaccinated. North Carolina Agricultural & Technical State University
had the most students (n=65, 47.45%) who indicated that they would like to be
vaccinated with the Gardasil vaccine.
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Figure 11.1 Gardasil Vaccinations by University
Graph shows Gardasil vaccinations by university NCAT
22.63%, NCCU 35.6%, ECU 31.5%, and UNCG 38.56.

Further analysis was conducted that observed Gardasil vaccination rates by
gender at each university (Table 18.1). More than half of the females at NCCU and
UNCG had been vaccinated with the Gardasil vaccine. Less than fifty percent of the
females at ECU and NCAT had been vaccinated. Almost 80% of females in all schools
have or would like to be vaccinated and almost 20% have no interest in receiving the
vaccination. Eighty percent of males from UNCG and 70% of males from ECU were not
vaccinated and expressed no interest in being vaccinated. Over, 60% of males that
attended NCAT and NCCU showed interest in receiving the Gardasil vaccine.
Males that attend the historically black colleges (NCAT and NCCU) were more
likely to have interest in being vaccinated with Gardasil. Males that attended universities
which were historically white (UNCG 81.9% and ECU 68.9%) had almost no interest in
vaccination. This means that the approach for increasing vaccination rates in males may
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need to be different according to ethnicity. In females, it is interesting that half of the
females from NCCU and UNCG had been vaccinated. Considering that NCCU is
historically black and UNCG is historically white. Females that attended NCAT and
ECU had less than 50% vaccination rates. There may be no major difference in
vaccination rates between women according to ethnicity because Merk Pharmaceutical
Company has spent millions of dollars to advertise Gardasil to a diversified group of
women between the ages of 9-26.

Table 18.1 Gardasil Vaccinations by University and Gender
ECU
NCA T
NCCU
M

F

M

F

M

UNCG
F

M

F

No, and not
interested

68.9%

20.8%

38%

21.2%

38.0%

16.7%

80.9%

21.7%

31.1%

29.0%

62.0%

31.8%

62.0%

25.9%

17.0%

23.6%

.0%

49.4%

.0%

47.0%

.0%

57.4%

2.1%

54.7%
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77

71

66

71

54

47

106

No, but
interested in
vaccine
Yes, I have
been
vaccinated
Total
(Frequency)
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4.12.3 Gardasil Vaccination by Classification. Next, we looked at Gardasil
vaccination across classification (Table 19.1). Freshmen and sophomores had the highest
percentage of respondents vaccinated with Gardasil. The majority of junior respondents
had not been vaccinated and did not want to be vaccinated with the vaccine. All students
showed interest in receiving the Gardasil vaccine. The different classifications showed
that students were divided by a third wanting the vaccine, a third not interested in the
vaccine and those that had been vaccinated. Chi-square test showed that there was no
significant difference in Gardasil vaccination rates based on the classification of students.

Table 19.1 Gardasil Vaccinations by Classification
Freshmen
Sophomores
Juniors

Seniors

Graduate
Students

No, and I
do not
want to be
vaccinated

29.6%

33.6%

37.7%

35.8%

42.1%

No, but I
would like
to be
vaccinated

36.2%

29.6%

32.7%

39.5%

42.1%

Yes, I
have been
vaccinated

34.2%

36.8%

29.6%

24.7%

15.8%
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4.12.4 Gardasil Vaccination and Community. Gardasil vaccinations were
compared to community. However, one hundred and fifty-five students failed to identify
their hometown (Table 20.1). Of the 350 students who did report their hometown,
students from rural communities were more likely to report that they did not want to be
vaccinated with Gardasil at a higher rate than students from urban communities. Higher
vaccination rates were seen in college students from urban communities. However, more
interest in Gardasil vaccination was seen in students from rural areas.
There is some difference in the communities and Gardasil vaccinations (x2=8.715,
p =.069). However due to the fact that half of the population failed to report their
hometown, it is difficult to draw definite conclusions. Further research needs to be
implemented to examine vaccination rates of students from rural and urban communities.
This information will further aid in the development of educational materials on HPV and
the Gardasil vaccine.

Table 20.1 Gardasil Vaccinations by Community
Rural

Urban

Non-Reported

No, and I do not
want to be
vaccinated
No, but I would like
to be vaccinated

37.0%

29.0%

38.1%

36.9%

38.3%

26.5%

Yes, I have been
vaccinated

26.2%

32.7%

35.5%
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4.12.5 Gardasil Vaccinations among Gender in Blacks and Whites. We also
looked at two ethnicities, Caucasian/White and African American/Black/African Descent,
to Gardasil vaccinations. Analysis showed that differences in responses of the two
ethnicities are statistically significant (x2 = 40.856, p = .001) (Table 21.1). Black males
(59.8%) would like to be vaccinated at a higher percentage of white males (19.4%).
White males (80.3%) showed no interest in receiving the Gardasil vaccine in comparison
to black males (38.4%). More than half of the black (52.2%) and white (58.5%) females
had been vaccinated with Gardasil. Nearly 80% of the females had been vaccinated or
would like to be vaccinated.
Of the students who had received the Gardasil vaccine, whites were more likely to
receive all three shots (80.3%); compared to blacks (67.8%). However, 20.8% of blacks
reported that it was not time for the next injection compared to whites (9.8%). The
reasons for not receiving all three shots of Gardasil differed between the two populations.
Blacks reported that they had not received all three vaccinations because of monetary
reasons or they just simply forgot to go back for other injections. Whites reported that
they had not received all three injections because of bad reactions and that they just
decided not to finish the series of vaccinations. The two populations had other reasons
that were similar for not receiving all of the injections, such as time conflicts, phobia of
needles, and being away from home at the time for the next injection.
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Table 21.1 Gardasil Vaccination based on Ethnicity and Gender
African American/
Black/African
Descent
N=273
M
F
No, and I do not want to be
38.4%
17.4%
Gardasil
vaccinated
No, but I would like to be
30.4%
59.8
vaccinated
%
Yes, I have been vaccinated
1.8%
52.2%
Total
n=112
n=161

Caucasian/
White
N=168
M
80.6%

F
20.7%

19.4%

20.8

0%
n=62

58.5%
n=
106

4.13 Perceived Barriers to Gardasil Vaccination
Based on the responses from college students, most had not been vaccinated with
Gardasil (66.3%), due to a lack of information on the vaccine and the disease. Financial
reasons, time conflicts, and personal reasons seemed to be common reasons students had
not been vaccinated. A moderate amount of college students reported that they had not
been vaccinated, because they were not concerned with contracting HPV (28.7%). These
students explained that they were mostly in committed monogamous relationships.
Other factors, such as religious reasons, not having a physician, and not feeling the need
to be vaccinated were of lesser concern (Table 22.1). There was not a major difference in
the reasons for non-vaccination among female and male respondents. More males
responded that they did not have enough information on the vaccine and disease, also
they were not concerned with contracting HPV in comparison to females. Females
reported that they have not been vaccinated due to personal reasons at a higher rate than
males.
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Overall, lack of information on the vaccine and disease seems to be the major
reason that two thirds of the population had not been vaccinated with Gardasil. If more
efforts were made to educate people on the human papillomavirus and the Gardasil
vaccine, maybe there would be higher vaccination rates and lower incidence of related
diseases.

Table 22.1 Reasons for not being vaccinated
Reasons for not being
% of Females
Vaccinated
Responses

% of Males
Responses

Percentage of
Population %

Lack of information on
the vaccine and disease

58%

72.3%

66.3%

Financial Reasons
Time Conflicts

18.2%
22.4%

15.9%
15.9%

16.9%
18.6%

Religious Reasons

2.1%

6.2%

4.4%

Personal Reasons

19.6%

8.7%

13.3%

I am not concerned
with contracting HPV

17.5%

36.9%

28.7%

I do not have a
physician

8.4%

5.6%

6.8%

I do not think the
vaccine is safe

22.4%

12.3%

16.6%

Other reasons

12.6%

9.2%

10.7%

No, because it would
benefit women only

0%

5.7%

3.3%

Total

145

197

342
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CHAPTER 5
Conclusions

Most would think that college students would be lined up, as they did for the
latest Apple gadget, the “iPad”, if they could acquire a vaccine to protect against the
number one sexually transmitted infection (STI) in the United States of America, the
human papillomavirus (HPV). However, our research showed that college students in
North Carolina are divided into thirds when it comes to the Gardasil vaccine. A third of
the population had been vaccinated, a third was interested in receiving the vaccine, and a
third was not interested in receiving the Gardasil vaccine. The most common perceived
barrier to vaccination by both men and women was a lack of information on the vaccine
and the associated diseases. The Merck Pharmaceutical Company, public health
agencies, universities, and communities must come together to educate young adults on
the benefits of being vaccinated with Gardasil.
A comparison of knowledge scores to ethnicity showed that Asian
American/Southeast Asian/Asian and Hispanics had the highest scores. Unfortunately,
we did not have significant numbers to represent the full population (n=22). This group
represented less than 5% of the total population. A larger sample of Asian
American/Southeast Asian/Asian and Hispanics would allow us to see if their higher
knowledge scores are significant. There may be a way these specific ethnic groups are
receiving more information about HPV that could benefit other ethnic groups.
The survey used in this study also should have asked females if they received a
Papanicolaou Test (Pap Smear) in the last year, and if so, if it were normal or abnormal.
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Abnormal cell changes on the cervix could be an indicator of cancerous cells on the
cervix or cells that could become cancerous in later years if not removed. It is important
for women who are sexually active to receive a pap smear, yearly, because cervical
cancer is the number two killer of women worldwide.
Another limitation to this study is that 155 students failed to report their
hometown. More research needs to be done to see if students from rural or urban
communities are more likely to be vaccinated. This may lead to a decision that there
needs to be a different approach in the development of educational materials for young
adults who are from the city than those who are from the country. Also, only 502
college students were surveyed from North Carolina; this cannot fully represent all of the
college students in North Carolina. This study also failed to sample students that
attended private colleges.
This study should have asked participants, if they were currently single, in a
monogamous relationship/married, or dating numerous partners. The data is showing
that white males are in a monogamous relationship at a higher rate than black males. By
asking the study participants what type of relationship they are in currently would have
provided more insight into the trending data.
Future surveys should sample a diverse group of ethnicities, religions, and
geographic locations as researchers continue to assess the knowledge, awareness and
perception of HPV in North Carolina, the United States, and the world. More public
health initiatives need to be implemented to educate men and women on the possible
benefits of the HPV vaccine Gardasil.
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Physicians should encourage students to contact the student health center at their
university for follow up injections; so that being away from home is not a reason for
students not receiving all three shots of Gardasil. The UNC system mandated that all
North Carolina college students be insured. If they were not on their parents or family
guardian’s insurance, they had the option of school insurance. There should not be any
females enrolled in college who are unable to receive Gardasil vaccinations due to
monetary reasons. The student health insurance policies need to explain to students so
that students are aware that a certain amount of money is allotted to students’ general
“Well Being.” To assure that well being, students should be informed that they can
receive the vaccination for close to no cost.
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APPENDIX A. SURVEY INSTRUMENT

Human Papillomavirus (HPV) Knowledge and Awareness
Among North Carolina College Students
This study will explore the knowledge and awareness of North Carolina college
students about the human papillomavirus (HPV). The study is being conducted by a
Master’s Candidate in the Department of Biology at North Carolina Agricultural &
Technical State University. Participation in this survey is completely voluntary. The
identity of survey participants will be kept confidential and anonymous. The
responses collected will be used solely for research purposes.
Directions: Please select the best single response to each question below, except where
asked for multiple responses. Please do not write your name anywhere on this form, so
that your information will remain anonymous.
1. What is your sex? Male

Female

2. What is your ethnicity?
□ African American/ Black
□ Asian American
□ Caucasian/ White
□ Hispanic/Latino
□ Native American
□ Other Please Specify
3. What is your age?
□ 18-22
□ 23-26
□ Older than 26
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4. What is your classification?
□ Freshman
□ Sophomore
□ Junior
□ Senior
□ Graduate Student
5. What do you consider to be your “home” (before coming to college)? (Please
print)
City: __________________ State: ________________

6. What is your major?
□ Biology/ Chemistry
□ Economics/ Business
□ Education
□ Engineering
□ Humanities/ Foreign Language
□ Mathematics/ Physics
□ Civics/ Social Sciences
□ Communication
□ Music/Theatre/Art
□ Nursing
□ Other Please Specify
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7. What are your sources for receiving information regarding sexually transmitted
diseases (STD’s) or infections (STI’s)? (Check all that apply)
□ Physician or Student Health Center
□ Television
□ Internet
□ Health Classes
□ Magazines, Books or Newspapers
□ Word of Mouth Please Circle (Parent/Guardian, Friends, Teacher,
Mentor)

8. When was your last annual physical or gynecological examination?
□ 6 months ago
□ A year ago
□ More than a year ago
□ Never
9. Are you sexually active?
□ Yes
□ No
10. How many sexual partners have you had in the last 3 years?
□ 0-1
□ 2-3
□ 4-5
□ More than 5
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Please answer the following questions about your knowledge of HPV and the
Gardasil HPV vaccine.
11. HPV is a bacterial disease?
□ True
□ False
12. HPV is the most common Sexually Transmitted Infection (STI) in the United
States?
□ True
□ False
13. HPV is associated with (Check all that apply)
□ Genital warts in males
□ Genital warts in females
□ Cervical cancer in females
□ Throat and penis cancers in males
□ Anal and oral cancers in males and females
14. Most types of HPV infections…………
□ Usually clear on their own
□ Sometimes clear on their own
□ Are unable to clear on their own and require medical attention

15. What is the chance that one will contract HPV in his or her lifetime?
□ 25% chance
□ 50% chance
□ 75% chance
□ 100% chance
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16. How many types of HPV infect the genital tract?
□ Only 1
□ Between 30-40
□ More than 100
17. Which sex does HPV usually infect?
□ Males more than females
□ Females more than males
□ Both are infected equally
18. A condom will prevent transmission of HPV between partners.
□ True
□ False
19. HPV can be transmitted through (Check all that apply)
□ Holding hands
□ French Kissing
□ Intimate skin to skin contact
□ Oral sex
□ Sexual intercourse
20. When could a person under 26 receive the HPV vaccine?
□ Before becoming sexually active
□ After becoming sexually active
□ After being exposed to the HPV virus
□ All of the above

72

21. How do you rate your knowledge of the human papillomavirus?
□ 1-2 Poor
□ 3-4 Average
□ 5-6 Well Informed
22. Have you ever been diagnosed with HPV?
□ Yes
□ No
23. The HPV Vaccine Gardasil has been approved to protect against genital warts and
cervical cancer. What is your attitude toward the vaccine?
□ Don’t know about the vaccine and not interested in receiving more
information on the vaccine
□ Don’t know about the vaccine but would like more information on the
vaccine
□ Have some information about the vaccine but would like more information
□ I know everything about the HPV vaccine
24. Did you know that the Gardasil vaccine has been approved for males?
□ Yes
□ No
25. Have you been vaccinated with the HPV vaccine Gardasil?
□ Yes (CONTINUE TO QUESTION 26)
□ No, but I would like to be vaccinated (SKIP TO QUESTION 26)
□ No, and I do not want to be vaccinated (SKIP TO QUESTION 26)
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26. Have you received all three injections of the Gardasil vaccine?
□ Yes
□ No, because it is not time for the next injection
□ No, because of another reason (explain)
Stop here……. Thank you for your participation!

27. If you answered NO to question 24, please check the reasons for not receiving the
Gardasil vaccine. Check your top 3 Reasons.
□ Lack of information on the vaccine and disease
□ Financial reasons
□ Time conflicts
□ Religious reasons
□ Personal reasons
□ I am not concerned with contracting HPV
□ I do not have a physician
□ I do not think the vaccine is safe
□ I do not feel I need the vaccine because
□ No, because it would benefit women only
………………………………………THE END….……………………………………..
Thank you for participating in this survey. The information gathered will be used in
the development of educational materials to increase students’ awareness on the
Human Papillomavirus the Gardasil vaccine and its link to various cancers. Some
questions were obtained from the Guilford County Public Health Department. If
you have any questions regarding this survey, please email Aliza Alston at
atalsto1@ncat.edu or contact Dr. Doretha B. Foushee at foushee@ncat.edu or (336)
285-2160.
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APPENDIX B. INFORMED CONSENT

INFORMED CONSENT TO PARTICIPATE IN A RESEARCH STUDY

Study Title: Human Papillomavirus (HPV) Knowledge and Awareness Among North Carolina
College Students
PI: Aliza Alston
Dear Respondent,
I am inviting you participate in a research project to study the Human Papillomavirus. Along with
this letter is a short questionnaire that asks a variety of questions about Human Papillomavirus. I
am asking you to look over the questionnaire and, if you choose to do so, complete it and return it
to me. This should require about ten minutes of your time. You must be 18 years of age to

participate in this study.
The results of this project will be analyzed. Through your participation I hope to understand the
knowledge of HPV on college campuses. I hope that the results of the survey will be useful for
use in designing materials to be used in educating college students on the Human Papillomavirus
in the future. I hope to share my results, by publishing them in a scientific journal.
I do not know of any risks to you if you decide to participate in this survey, and I guarantee that
your responses will not be identified with you personally. I promise not to share any information
that identifies you with anyone outside my research group which consists of my advisory
committee. If you do not feel comfortable handing in your survey to me, you may also mail it to
the Biology Department at North Carolina Agricultural & Technical State University.
I hope you will take the time to complete this questionnaire and return it. Your participation is
voluntary and there is no penalty if you do not participate. Regardless of whether you choose to
participate, please let me know if you would like a summary of my findings. To receive a
summary, email me at atalsto1@ncat.edu.
If you have any questions or concerns about completing the questionnaire or about being in this
study, you may contact me at atalsto1@ncat.edu. You may also contact my research advisor at
foushee@ncat.edu. This project has been approved by the Institutional Review Board (IRB) at
North Carolina A&T State University.
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If you have any questions about your rights as a research study participant, you may contact the
chair of the IRB through the North Carolina A & T State University Compliance Office at (336)
334-7995 or rescomp@ncat.edu.
If you agree to participate, you may keep this form and complete the survey.
If you wish, you may skip any question or stop at any time.

Sincerely.

Aliza Alston
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ECU CONSENT FORM
Title of Research Study:
Human Papillomavirus (HPV) Knowledge and Awareness Among North Carolina
College Students
Principal Investigator:
Contact Faculty Member:
Institution:
Address:

Aliza Alston
Dr. Jason Bond, Department of Biology
East Carolina University
Howell Science Complex, Greenville, NC 27858

INTRODUCTION
You are invited to participate in a research project to study the Human Papillomavirus.
My name is Aliza Alston, and I am a graduate student at North Carolina Agricultural &
Technical State University (NCA&TSU) currently pursuing a Master’s degree in
Biology. This study constitutes the research aspect of my Master’s thesis. I obtained my
BS degree in Biology in 2009 from East Carolina University. Dr. Bond was my field
zoology teacher.
PLAN AND PROCEDURES
If you decide to participate, you will be asked to fill out a questionnaire assessing various
aspects of demographic information, knowledge and awareness of HPV and its
vaccinations. We expect that your participation today will take approximately 10 minutes
to complete. I do intend to publish my results in a scientific journal.
METHODS
This survey will be administered face to face to willing participants. Students will be
recruited to participate in this study by several methods. Areas of surveillance include
dining halls, student unions, plots, and the surrounding areas outside of the libraries.
Secondly, an email will be sent to professors with students from different majors (Health,
Biology 100, Psychology, English, etc.) informing them of an important study being
conducted by a NCA&TSU graduate student. The email would simply ask professors, “If
I may come to their classrooms at their convenience.” Lastly, I plan to contact
organizational leaders on campus. I plan to do this to see if it is possible to pass out my
survey during a group function.
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POTENTIAL RISKS AND DISCOMFORTS
We anticipate that this study poses no potential risks. However, in the event that you are
uncomfortable answering any question, please feel free to leave the question(s) blank.
POTENTIAL BENEFITS
Participation in the study will be used to design educational materials to educate college
students on the Human Papillomavirus.
SUBJECT PRIVACY AND CONFIDENTIALITY OF RECORDS
Participation in this survey is completely voluntary. The identity of survey participants
will be kept confidential and the responses collected will be used solely for research
purposes. Information obtained in this study, will be known only to the principal
investigator, researcher, and my advisory team. The results of the study will be reported
in summary format, and no personally identifying information will be included on the
survey form or with the results of the study. Completed surveys will be kept in a safe
place and destroyed in 2017.
COSTS OF PARTICIPATION
There will be no additional costs to you resulting from participation in this study.
VOLUNTARY PARTICIPATION
Participating in this study is voluntary. There is no penalty if you do not participate.
Regardless of whether you choose to participate, please let me know if you would like a
summary of my findings. To receive a summary, email me at atalsto1@ncat.edu.
PERSONS TO CONTACT WITH QUESTIONS
The investigator will be available to answer any questions concerning this research, now
or in the future. You may contact the investigator, Aliza Alston, by email at
atalsto1@ncat.edu. If you have questions about your rights as a research participant you
may call the ECU Chair of the University and Medical Center Institutional Review Board
at phone number 252-744-2914.
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CONSENT TO PARTICIPATE
I have read all of the above information, and have received satisfactory explanations in
areas I did not understand, if any. (A copy of this signed and dated consent form will be
provided to you if desired).
_______________________________________________________________
Participant’s Name (PRINT)
Signature
Date Time
PRINCIPAL INVESTIGATOR: I confirm that the participant has read the contents of
this consent document, the participant has indicated all questions have been answered to
his or her satisfaction, and the participant has signed the document.
________________________________________________________________
Principal Investigator’s Name (PRINT)
Signature
Date Time
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APPENDIX C. INSTITUTIONAL REVIEW BOARD APPROVAL
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Office of Research Compliance
2718 Beverly Cooper Moore and Irene Mitchell Moore
Humanities and Research Administration Building
P. O. Box 26170, Greensboro, NC 27402-6170
336.256.1482 Phone 336.256.1482 Fax

October 25, 2010

Aliza Alston
104 Barnes Hall

Dear Ms. Alston:
The IRB for the Protection of Human Participants in Research at The University of North
Carolina at Greensboro (UNCG) is willing to accept the approval of project entitled
“Human Papillomavirus (HPV) Knowledge and Awareness Among North Carolina
Students” by A& T University. Access to participants on this campus must be cleared
through the appropriate department prior to you collecting data on the UNCG campus.
If you have any questions, please contact me at ecallen@uncg.edu or (336) 256-1482.
Sincerely,

Eric Allen, Director
Office of Research Compliance
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